Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Humacyte Inc (HUMA)

Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Results from Humacyte’s V007 Pivotal Phase 3 AV Access Study Highlighted by Presentation at the Society for Vascular Surgery Meeting

HUMA : 2.41 (+1.69%)
Humacyte Clinical Results in High-Risk Dialysis Patients from V007 Pivotal Phase 3

HUMA : 2.41 (+1.69%)
Humacyte to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq

HUMA : 2.41 (+1.69%)
Humacyte Announces First Quarter 2025 Financial Results and Provides Business Update

HUMA : 2.41 (+1.69%)
Humacyte to Present First Quarter Financial Results and Provide Corporate Update on May 13, 2025

HUMA : 2.41 (+1.69%)
Humacyte Stock Continues Slide Despite Lower Than Expected Q4 Loss – But Retail Gets More Bullish

Fourth-quarter loss per share came in at $0.16, lower than the $0.24 in the corresponding period of 2023, and below the consensus estimate of $0.25, according to FinChat data.

HUMA : 2.41 (+1.69%)
VTI : 296.47 (+0.99%)
IWM : 210.77 (+1.18%)
Humacyte Announces Fourth Quarter and Year End 2024 Financial Results and Provides Business Update

HUMA : 2.41 (+1.69%)
Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 28, 2025

HUMA : 2.41 (+1.69%)
Humacyte, Inc. Announces Pricing of Public Offering of Common Stock

HUMA : 2.41 (+1.69%)
Humacyte, Inc. Announces Proposed Public Offering of Common Stock

HUMA : 2.41 (+1.69%)

Barchart Exclusives

Warren Buffett Loves This Cheap Dividend Stock and So Do Company Insiders
With Warren Buffett’s Berkshire Hathaway holding over 28% of its shares and company insiders also buying in, Occidental Petroleum is a cheap energy stock with strong fundamentals. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar